150 related articles for article (PubMed ID: 11151060)
21. The prognostic role of tumor associated glycoprotein 72 (TAG-72) in stage II and III colorectal adenocarcinoma.
Cho J; Kim KM; Kim HC; Lee WY; Kang WK; Park YS; Ha SY
Pathol Res Pract; 2019 Jan; 215(1):171-176. PubMed ID: 30466765
[TBL] [Abstract][Full Text] [Related]
22. Expression of CEA, Tag-72, and Lewis-Y antigen in primary and metastatic lesions of ovarian carcinoma.
Chhieng DC; Rodriguez-Burford C; Talley LI; Sviglin H; Stockard CR; Kleinberg MJ; Barnes MN; Partridge EE; Khazaeli MB; Grizzle WE
Hum Pathol; 2003 Oct; 34(10):1016-21. PubMed ID: 14608535
[TBL] [Abstract][Full Text] [Related]
23. Molecular alterations in colitis-associated colorectal neoplasia: study from a low prevalence area using magnifying chromo colonoscopy.
Shivakumar BM; Kumar BL; Bhat G; Suvarna D; Rao L; Pai CG; Satyamoorthy K
J Crohns Colitis; 2012 Jul; 6(6):647-54. PubMed ID: 22398042
[TBL] [Abstract][Full Text] [Related]
24. p53 and prognosis in colorectal cancer.
Smith DR; Goh HS
Ann Acad Med Singap; 1996 Jan; 25(1):107-12. PubMed ID: 8779527
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients?
Kim HJ; Kim N; Choi YJ; Yoon H; Shin CM; Park YS; Lee HS; Ahn SH; Park do J; Kim HH; Son IT; Kang SB; Lee DH
Gastric Cancer; 2016 Jul; 19(3):798-807. PubMed ID: 26445944
[TBL] [Abstract][Full Text] [Related]
26. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
[TBL] [Abstract][Full Text] [Related]
27. The prognostic value of p73 overexpression in colorectal carcinoma: a clinicopathologic, immunohistochemical, and statistical study of 204 patients.
Toumi AA; El Hadj Oel A; Ben Mahmoud LK; Ben Hmida Ael M; Chaar I; Gharbi L; Mzabi S; Bouraoui S
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):128-36. PubMed ID: 19956069
[TBL] [Abstract][Full Text] [Related]
28. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
Knychalski B; Lukieńczuk T
Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
[TBL] [Abstract][Full Text] [Related]
29. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
[TBL] [Abstract][Full Text] [Related]
30. HMGB1-RAGE signaling facilitates Ras-dependent Yap1 expression to drive colorectal cancer stemness and development.
Qian F; Xiao J; Gai L; Zhu J
Mol Carcinog; 2019 Apr; 58(4):500-510. PubMed ID: 30456802
[TBL] [Abstract][Full Text] [Related]
31. Clinical Significance of Stanniocalcin2 mRNA Expression in Patients With Colorectal Cancer.
Watanabe T; Shiozawa M; Kimura Y; Hiroshima Y; Hashimoto I; Komori K; Watanabe H; Kano K; Fujikawa H; Aoyama T; Numata M; Yamada T; Tamagawa H; Ogata T; Yukawa N; Morinaga S; Rino Y; Masuda M; Miyagi Y; Oshima T
Anticancer Res; 2021 Apr; 41(4):2117-2122. PubMed ID: 33813422
[TBL] [Abstract][Full Text] [Related]
32. The prognostic value of the immunohistochemical aspects of tumor suppressor genes p53, bcl-2, PTEN and nuclear proliferative antigen Ki-67 in resected colorectal carcinoma.
Ghiţă C; Vîlcea ID; Dumitrescu M; Vîlcea AM; Mirea CS; Aşchie M; Vasilescu F
Rom J Morphol Embryol; 2012; 53(3):549-56. PubMed ID: 22990545
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma.
Manne U; Myers RB; Moron C; Poczatek RB; Dillard S; Weiss H; Brown D; Srivastava S; Grizzle WE
Int J Cancer; 1997 Jun; 74(3):346-58. PubMed ID: 9221816
[TBL] [Abstract][Full Text] [Related]
34. Molecular Subtypes of Colorectal Cancer and Their Clinicopathologic Features, With an Emphasis on the Serrated Neoplasia Pathway.
Bae JM; Kim JH; Kang GH
Arch Pathol Lab Med; 2016 May; 140(5):406-12. PubMed ID: 27128298
[TBL] [Abstract][Full Text] [Related]
35. TAG-72 (CA 72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer.
Guadagni F; Roselli M; Cosimelli M; Mannella E; Tedesco M; Cavaliere F; Grassi A; Abbolito MR; Greiner JW; Schlom J
Cancer; 1993 Oct; 72(7):2098-106. PubMed ID: 8374868
[TBL] [Abstract][Full Text] [Related]
36. High expression of sLex associated with poor survival in Argentinian colorectal cancer patients.
Zwenger A; Rabassa M; Demichelis S; Grossman G; Segal-Eiras A; Croce MV
Int J Biol Markers; 2014 Mar; 29(1):e30-9. PubMed ID: 24425323
[TBL] [Abstract][Full Text] [Related]
37. ECA39 is a novel distant metastasis-related biomarker in colorectal cancer.
Yoshikawa R; Yanagi H; Shen CS; Fujiwara Y; Noda M; Yagyu T; Gega M; Oshima T; Yamamura T; Okamura H; Nakano Y; Morinaga T; Hashimoto-Tamaoki T
World J Gastroenterol; 2006 Sep; 12(36):5884-9. PubMed ID: 17007058
[TBL] [Abstract][Full Text] [Related]
38. Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewis(a) and sialyl-Lewis(x) antigens in colorectal adenocarcinoma.
Baldus SE; Mönig SP; Hanisch FG; Zirbes TK; Flucke U; Oelert S; Zilkens G; Madejczik B; Thiele J; Schneider PM; Hölscher AH; Dienes HP
Histopathology; 2002 May; 40(5):440-9. PubMed ID: 12010364
[TBL] [Abstract][Full Text] [Related]
39. P53 overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection.
Liang JT; Huang KC; Cheng YM; Hsu HC; Cheng AL; Hsu CH; Yeh KH; Wang SM; Chang KJ
Int J Cancer; 2002 Feb; 97(4):451-7. PubMed ID: 11802206
[TBL] [Abstract][Full Text] [Related]
40. Expression of NOX Family Genes and Their Clinical Significance in Colorectal Cancer.
Cho SY; Kim JS; Eun HS; Kang SH; Lee ES; Kim SH; Sung JK; Lee BS; Jeong HY; Moon HS
Dig Dis Sci; 2018 Sep; 63(9):2332-2340. PubMed ID: 29781053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
